Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2019

Open Access 01-12-2019 | Anemia | Research article

Blood donors deferral prevalence and causes in a tertiary health care hospital, southern Nigeria

Authors: Henshaw Uchechi Okoroiwu, Enosakhare Aiyudubie Asemota

Published in: BMC Health Services Research | Issue 1/2019

Login to get access

Abstract

Background

Blood transfusion is a life-saving intervention. However, the safety of the donor and the recipient is paramount. This study was aimed at determining the blood donation deferral pattern of University of Calabar Teaching Hospital.

Methods

A retrospective analysis of the prospective donors’ data of University of Calabar Donor clinic within the period of March 2015 to February 2016 was conducted. Data were extracted from the donor register and analyzed. Prospective donors were screened and interviewed for causes of temporary and permanent deferrals.

Result

Out of the 1886 screened prospective donors, 164 (8.69%) were deferred. Though the minority of the donor population, female donors had the highest deferral rate (33.33%). There were 31.10 and 68.90% cases of temporary and permanent deferrals, respectively. Hepatitis B virus (HBV) was the highest (31.71%) cause of overall deferral as well as permanent deferral. Anemia was the major (21.95%) cause of temporary deferral as well as the second cause of overall deferrals. Commercial and replacement donors constituted 68.28 and 31.71% of the deferral cases, respectively.

Conclusion

HBV was found to be the overall leading cause of deferral in the studied area. This outcome poses a public health concern and should elicit measures to curb the infection rate.
Literature
1.
Okoroiwu HU, Okafor IM. Demographic characteristics of blood and blood components transfusion recipients and pattern of blood utilization in a tertiary health institution in southern Nigeria. BMC Hematol. 2018;18:16.CrossRef
2.
Aneke CJ, Ezeh UT, Nwosu AG, Anumba EC. Retrospective evaluation of prospective blood donor deferral in a tertiary hospital-based blood bank in south-East Nigeria. J Med Tropics. 2016;18(2):103–7.CrossRef
3.
Chauhan DN, Desai KN, Trivedi HJ, Agnihotri AS. Evaluation of blood donor deferral causes: a tertiary-care Centre-based study. Int J Med Sci Public Health. 2015;4(3):289–392.CrossRef
4.
Chauhan C, Chauhan R, Awasthi S, Dutta S, Joshi H. Pattern and outcome of donor deferral-? Need of hour. Int J Res Med Sci. 2018;6(1):289–92.CrossRef
5.
Newman B. Blood donor suitability and allogenic whole blood donation. Transfus Med Rev. 2001;15:234–44.CrossRef
6.
Bahadur S, Jain S, Goel RK, Pahuja S, Jain M. Analysis of blood donor deferral characteristics in Delhi, India. Southeast Asian J Trop Med Public Health. 2009;40:1087–91.PubMed
7.
Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation. BMC Public Health. 2018;18:645.CrossRef
8.
World Health Organization (WHO). Donor selection guidelines on assessing donor suitability for blood donation. Luxemburg: WHP cataloguing-in-publication data; 2012. p. 35.
9.
National Blood Transfusion Service. Federal Ministry of Health, Nigeria. Nigeria National Blood Policy Revised. Abuja: National Blood Transfusion Science, Federal Ministry of Health; 2006. p. 1–16.
10.
National Blood Transfusion Service, Federal Ministry of Health [Nigeria]. The National Blood Policy. Abuja: National Blood Transfusion Service, Federal Ministry of Health Abuja; 2006.
11.
Ahmed SG, Ibrahim UA, Hassan AW. Adequacy and pattern of blood donation in North-Eastern Nigeria: the implications for blood safety. Ann Trop Med Parasitol. 2007;101(8):725–31.CrossRef
12.
Aneke JC, Okocha CE. Blood transfusion safety; current status and challenges in Nigeria. Asian J Transfus Sci. 2017;11(1):1–5.CrossRef
13.
Nwabueze BO. A constitutional history of Nigeria. United Kingdom: C Hurst and Co LTD; 1982.
14.
15.
National Population Commission. Population Council Report of Nigeria’s National Population Commission on the 2006 census. Popul Dev Rev 2007; 33(1):206–210.
16.
World Health Organization. Current status on blood safety and availability in the WHO African Region-Report of the 2013 survey. Geneva.: WHO Regional office for Africa.: World Health Organization; 2017. License: CCBY-NC-SA 3.0 IGO
17.
Okocha EC, Aneke JC, Ezeh TU, Ibeh NC, Nwosu GA, Okorie IO, et al. The epidemiology of transfusion-transmissible infection among blood donors in Nnewi, Southeast Nigeria. Afr J Med Health Sci. 2015;14:125–9.CrossRef
18.
Noubiap JJ, Jojo WY, Nansseu JRN, Tene UG, Siaka G. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C virus and syphilis infection among first time donors in Edea, Cameroon. Int J Infect Dis. 2013;17(10):e832–7.CrossRef
19.
Birhaneselassie M. Prevalence of transfusion transmissible infections in donors in Ethiopian blood bank between 2009 and 2013 and donation factors that would improve the safety of blood supply in underdeveloped countries. Lab Med. 2016;47(2):134–9.CrossRef
20.
Rehman S, Arif SH, Mehdi G, Saeed N, Yusuf F. The evaluation of blood donor deferral causes: a tertiary care Centre-based study. J Blood Disorders Transf. 2012;3:131.
21.
Zaheer HA, Saeed U, Waheed Y, Karimi S, Waheed U. Prevalence and trend of hepatitis B, hepatitis C and human immunodeficiency virus among blood donors in Islamabad, Pakistan 2005-2013. J Blood Disorders Transf. 2014;5(6):1–5.
22.
Alvarado-Esquivel C, Rascon-Careaga A, Liesenfield O. Seroprevalance and associated risk factors for toxoplasma gondii infection in healthy blood donors; a cross sectional study in senora, Mexico. Biomed Res Int. 2016;9597276:8.
23.
Ekwere TA, Ino-Ekanem M, Motilewa OO, Ibanga IA. Pattern of blood deferral in a tertiary hospital, south-south, Nigeria: a three-year study review. Int J Blood Transfus Immunohematol. 2014;4:7–13.CrossRef
24.
Das S. Blood donor deferral pattern is a rural teaching hospital. Natl J Lab Med. 2012;1(1):1–6.
25.
Abdelaal M, Answer F. Analysis of blood donor deferral in Jeddah, Saudi Arabia: characteristics and causes. J Pak Med Assoc. 2016;66(11):1392–5.PubMed
26.
Waheed U, Zaheer HA. Evaluation of deferral pattern among the blood donors in Islamabad, Pakistan. Transfus Med. 2016;1:81–4.CrossRef
27.
Chenna D, Shastry S, Murugesan M, Baliga PB. Implication of deferral pattern on the donor pool: study at a tertiary care hospital. J Appl Hematol. 2015;6:111–4.CrossRef
28.
Alkantara JC, Alenezi FK, Cruz CP, Alcantara TY. Donor deferral pattern of a hospital-based blood bank in Saudi Arabia. Int Blood Res Rev. 2016;5(4):1–9.CrossRef
29.
Kasraian L, Negarestan N. Rates and reasons for blood donor deferral, shiraz, Iran. A retrospective study. Sao Paulo Med J. 2015;133(1):36–42.CrossRef
30.
Zou S, Musavi F, Notari EP, Rios JA, Trouern-Trend J, Fang CT. Donor deferral and resulting donor loss at American red Cross blood services, 2001 through 2006. Transfusion. 2008;48(12):2531–9.CrossRef
31.
Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Hirschler NV, et al. Quantifying loses to the donated blood supply due to donor deferral and miscollection. Transfusion. 2004;44(10):1417–26.CrossRef
32.
Aslan O. Whole blood deferral rate and characteristics of the Turkish population. Tranfus Med. 2007;17(5):379–83.CrossRef
33.
Valerian DM, Mauka WI, Kajeguka DC, Mgabo M, Juma A, Baliyima L, et al. Prevalence and causes of blood donor deferral among clients presenting for blood donation in northern Tanzania. PLoS One. 2018;13(10):e0206487.CrossRef
34.
Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg Seroprevalence and endemicity. Vaccine. 2012;30:2212–9.CrossRef
35.
World Health Organization (WHO). The global prevalence of anemia in 2011. Geneva: World Health Organization (WHO); 2011.
36.
Sarvaiya AN, Chauhan SC, Patel BH. Blood donor deferral pattern analysis in a tertiary care Centre: a study of 4902 subjects. Indian J Pathol. 2017;2:354–9.CrossRef
37.
Agnihotri N. Whole blood donor deferral analysis at a Centre in Western India. Asian J Tranfus Sci. 2010;4:116–22.CrossRef
38.
Meinia SK, Sawhney V. Analysis of donor deferral rate and its various causes in voluntary and replacement blood donor in Jammu, India. Int J Heal Sci Res. 2016;6:49–56.
39.
Stockx J, Gillet P, De Weggheleire A, Casas Maendaenda R, Beulane AJ, et al. Seroprevalence of transfusion transmissible infections and evaluation of the predonation screening performance at the provincial hospital of Tete Mozambique. BMC Infect Dis. 2011;11:141.CrossRef
40.
World Health Organization. Towards 100% voluntary blood donation a global framework for action. Geneva; 2010.
41.
Buseri FI, Muhibi MA, Jeremiah ZA. Seroepidemiology of transfusion transmissible infections among blood donors in Osogbo, Southwest Nigeria. Blood Transfus. 2009;7:293–7.PubMedPubMedCentral
42.
43.
44.
Olayinka AT, Oyemakinde A, Balogun MS, Ajudua A, Nguku P, Aderinola M, et al. Seroprevalence of hepatitis B infection in Nigeria: a national survey. Am J Prop Med. 2016;95(4):902–7.
45.
46.
47.
Imoru M, Eke C, Adegoke A. Prevalence of hepatitis B surface antigen (HBsAg), hepatitis C virus and human immunodeficiency virus (HIV) among blood donors in Kano Nigeria. J Med Lab Sci. 2003;12:59–63.
48.
Presidential Emergency Plan for AIDS Relief (PEPFAR). PEPFAR strategy country factsheet: Nigeria. Available at: www.​pepfar.​gov. Accessed 19 Nov 2018.
49.
50.
51.
52.
53.
54.
Shrivastava M, Shah N, Navaid S, Agarwal K, Sharma G. Blood donor selection and deferral pattern as an important tool for blood safety in a tertiary hospital. Asian J Transfus Sci. 2016;10(2):122–6.CrossRef
55.
Okafor IM, Okpokam DC, Antai AB, Usanga EA. Iron status of pregnant women in rural and urban communities of Cross River state, south-south, Nigeria. Niger J Physiol Sci. 2016;31:121–5.
56.
Msuya SE, Hussein TH, Uriyo J, Sam NE, Stray-Pedersen B. Anemia among pregnant women in northern Tanzania: prevalence risk factors and effect and perinatal outcomes. Tanzania J Health Res. 2011;13:33–9.CrossRef
57.
World Health Organization (WHO). Safe blood donation. Geneva: World Health Organization; 2009.
58.
Mittai R, Marwaha N, Basu J, Mohan H, Ravi KA. Evaluation of iron stores in blood donors by serum ferritin. Indian J Med Res. 2006;124:641–6.
59.
Caneado RD, Chiattone CS, Alonso FF, Langhi-Junior DM, Alves-Rde C. Iron deficiency in blood donors. Sao Paulo Med J. 2001;119:132–4.CrossRef
60.
Mast AE, Schlumpf KJ, Wright DJ, Custer B, Spencer B, Murphy EL, et al. Demographic correlates of low hemoglobin deferral among prospective whole blood donors. NHBLI retrovirus epidemiology donor study-II. Transfusion. 2010;50(8):1794–802.CrossRef
61.
Mast AE. Low hemoglobin deferral in blood donors. Transfus Med Rev. 2014;28(1):18–22.CrossRef
62.
63.
Mast AE, Steele WR, Johnson B, Wright DJ, Cable RG, Carey P, et al. Population-based screening for anemia using first-time blood donors. NHLBI retrovirus epidemiology donor study-II (REDS-II) investigators. Am J Hematol. 2012;87(5):496–502.CrossRef
64.
Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, et al. Iron deficiency in blood donors: the REDS-II donor iron status evaluation (RISE). NHLBI retrovirus epidemiology donor study-II (REDS-II). Transfusion. 2012;52(4):702–11.CrossRef
65.
Mast AE, Foster TM, Pinder HL, Beczkiewicz CA, Bellissimo DB, Murphy AT, et al. Behavioral, biochemical and genetic analysis of iron metabolism in high-intensity blood donors. Transfusion. 2008;48(10):2197–204.CrossRef
66.
Custer B, Chinn A, Hirschler NV, Busch MP, Murphy EL. The consequences of temporary deferral on future whole blood donation. Transfusion. 2007;47(8):1514–23.CrossRef
67.
Custer B, Schlumpt K, Wright D, Simon T, Wilkinson S, Ness P. Donor return after temporary deferral. Transfusion. 2011;51(6):118–1196.CrossRef
Metadata
Title
Blood donors deferral prevalence and causes in a tertiary health care hospital, southern Nigeria
Authors
Henshaw Uchechi Okoroiwu
Enosakhare Aiyudubie Asemota
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2019
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-019-4352-2

Other articles of this Issue 1/2019

BMC Health Services Research 1/2019 Go to the issue

Research article

Evaluation of facility and community-based active household tuberculosis contact investigation in Ethiopia: a cross-sectional study

Research article

Outcomes of aortic aneurysm surgery in England: a nationwide cohort study using hospital admissions data from 2002 to 2015

Research article

A critical analysis of purchasing arrangements in Kenya: the case of micro health insurance

Research article

The structure of the quality of clinical practice guidelines with the items and overall assessment in AGREE II: a regression analysis

Research article

Transcultural adaption and preliminary evaluation of “understanding low back pain” patient education booklet

Research article

Utilization willingness of institutional care between disabled and non-disabled seniors: evidence from Jiangsu, China